Paradigm Biopharmaceuticals Ltd.ASX: PAR

Aus ethics approval received for phase 3 trial

Sep 24, 2021 at 2:52 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment